1. Home
  2. ETNB vs HUT Comparison

ETNB vs HUT Comparison

Compare ETNB & HUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • HUT
  • Stock Information
  • Founded
  • ETNB 2018
  • HUT 2011
  • Country
  • ETNB United States
  • HUT United States
  • Employees
  • ETNB N/A
  • HUT N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • HUT Finance: Consumer Services
  • Sector
  • ETNB Health Care
  • HUT Finance
  • Exchange
  • ETNB Nasdaq
  • HUT Nasdaq
  • Market Cap
  • ETNB 1.5B
  • HUT 1.7B
  • IPO Year
  • ETNB 2019
  • HUT N/A
  • Fundamental
  • Price
  • ETNB $10.12
  • HUT $21.90
  • Analyst Decision
  • ETNB Strong Buy
  • HUT Strong Buy
  • Analyst Count
  • ETNB 8
  • HUT 14
  • Target Price
  • ETNB $26.43
  • HUT $26.64
  • AVG Volume (30 Days)
  • ETNB 2.2M
  • HUT 6.9M
  • Earning Date
  • ETNB 08-04-2025
  • HUT 08-12-2025
  • Dividend Yield
  • ETNB N/A
  • HUT N/A
  • EPS Growth
  • ETNB N/A
  • HUT N/A
  • EPS
  • ETNB N/A
  • HUT N/A
  • Revenue
  • ETNB N/A
  • HUT $132,459,000.00
  • Revenue This Year
  • ETNB N/A
  • HUT $74.79
  • Revenue Next Year
  • ETNB N/A
  • HUT $116.78
  • P/E Ratio
  • ETNB N/A
  • HUT N/A
  • Revenue Growth
  • ETNB N/A
  • HUT 0.24
  • 52 Week Low
  • ETNB $4.16
  • HUT $8.73
  • 52 Week High
  • ETNB $11.84
  • HUT $31.95
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 58.34
  • HUT 69.82
  • Support Level
  • ETNB $9.45
  • HUT $17.03
  • Resistance Level
  • ETNB $10.34
  • HUT $18.88
  • Average True Range (ATR)
  • ETNB 0.52
  • HUT 1.25
  • MACD
  • ETNB -0.07
  • HUT 0.32
  • Stochastic Oscillator
  • ETNB 69.34
  • HUT 93.92

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About HUT Hut 8 Corp.

Hut 8 Corp is an energy infrastructure operator and Bitcoin miner with self-mining, hosting, managed services, and traditional data center operations across North America. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.

Share on Social Networks: